FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

434132009: Eltrombopag olamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2742683013 Eltrombopag olamine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2768571019 Eltrombopag olamine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eltrombopag olamine Is a Eltrombopag false Inferred relationship Existential restriction modifier
Eltrombopag olamine Has disposition Thrombopoietin receptor agonist true Inferred relationship Existential restriction modifier
Eltrombopag olamine Is a Substance with thrombopoietin receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Eltrombopag olamine Is a Benzoic acid and/or benzoic acid derivative true Inferred relationship Existential restriction modifier
Eltrombopag olamine Is a Hydrazine and/or hydrazine derivative true Inferred relationship Existential restriction modifier
Eltrombopag olamine Is a Pyrazole and/or pyrazole derivative true Inferred relationship Existential restriction modifier
Eltrombopag olamine Is modification of Eltrombopag true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier 1
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag (as eltrombopag olamine) 50 milligram/1 each conventional release oral tablet (clinical drug) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 25mg oral powder sachets sugar free Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 25mg oral powder sachets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 25mg oral powder sachets sugar free 30 sachet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 25mg oral powder sachets (Novartis Pharmaceuticals UK Ltd) 30 sachet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 50mg tablets 28 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 50mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 50 milligram/1 each conventional release oral tablet Has specific active ingredient False Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 25mg tablets 28 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 25mg tablets (GlaxoSmithKline UK Ltd) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Has specific active ingredient False Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 12.5mg tablets 30 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Promacta 12.5mg tablets (Imported (United States)) 30 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Product containing precisely eltrombopag 75 milligram/1 each conventional release oral tablet Has specific active ingredient False Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 30 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Promacta 75mg tablets (Imported (United States)) 30 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Eltrombopag 75mg tablets 28 tablet Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier
Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient True Eltrombopag olamine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start